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Lanthanides compete with calcium for binding
to cadherins and inhibit cadherin-mediated
cell adhesion†
Lewis L. Brayshaw, a Rosanna C. G. Smith, ab Magd Badaoui,c James A. Irvingc
and Stephen R. Price *a
Lanthanides are rare-earth metals with a broad range of applications in biological research and medicine.
In addition to their unique magnetic and spectroscopic properties, lanthanides are also eﬀective mimics of
calcium and can stimulate or inhibit the function of calcium-binding proteins. Cadherins are a large family of
calcium-binding proteins that facilitate cell adhesion and play key roles in embryo development, tissue
homeostasis and tumour metastasis. However, whether lanthanides can bind cadherins and functionally
replace calcium binding has not been comprehensively explored. In this study, we investigated the eﬀect of
lanthanide binding on cadherin structure and function using terbium, which is a commonly used lanthanide
for protein spectroscopy and a proposed anti-cancer agent. We demonstrate that terbium can compete
with calcium for binding to calcium-binding sites in cadherins. Terbium binding to cadherins abolished their
cell adhesive activity and rendered cadherins sensitive to proteolysis by trypsin. Molecular dynamics
simulations indicate that replacement of calcium by terbium results in structural rearrangements and
increases the flexibility of the cadherin ectodomain. These changes in structure and dynamics are likely to
underlie the inability of lanthanide-bound cadherins to support cell adhesion. Taken together, our findings
further knowledge on lanthanide interactions with calcium-binding proteins and provide new insight into the
influence of metal chemistry on cadherin structure, dynamics and function.
Significance to metallomics
Lanthanides are widely used in medicine and biological research. A unique feature of lanthanides is their ability to mimic calcium in biological processes and
the binding of lanthanides is known to induce a range of eﬀects in calcium-binding proteins. This study investigated the eﬀect of lanthanides binding to
cadherins, which are calcium-dependent cell adhesion molecules that have key roles in embryo development and tumour metastasis. Our findings expand
knowledge on the bioactivity of lanthanides and provide new insight into the sensitivity of cadherin function to the chemistry of binding metals.
Introduction
Lanthanides are a group of metals with extensive use in bio-
logical research and medicine.1–4 They are frequently used in
clinical magnetic resonance imaging and, due to their spectro-
scopic properties, are powerful tools for probing physiological
processes. For example, lanthanides have been used to monitor
E- and N-cadherin dynamics in the membranes of cells undergoing
epithelial-to-mesenchymal transition.5 Additionally, lanthanides
are highly bioactive and there is significant interest in their use
as therapeutics.6 Lanthanum carbonate for instance, is a potent
binder of phosphate and is an approved treatment for hyper-
phosphatemia in patients with chronic kidney disease.7
Furthermore, considerable research exists to support the use of
lanthanides (in particular Tb3+ and Gd3+) as anti-cancer agent,
given their ability to induce apoptosis and inhibit cell motility in
cancer cells.8–11
A significant characteristic of lanthanide ions is their
chemical similarity to Ca2+ ions, which is a result of their
comparable ionic radii and metal coordination chemistry.12
For example, Tb3+ has an ionic radius of 0.98 Å and Ca2+ has an
ionic radius of 1.06 Å, and both are typically coordinated by 6–8
ligands.13–15 Lanthanides binding within a number of Ca2+-binding
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proteins has been demonstrated, and due to their greater electro-
positivity, lanthanides often have a stronger binding affinity to
proteins than Ca2+.16,17 However, the effect that lanthanide
binding has on the function of proteins is hard to predict. For
certain proteins, lanthanide binding has been shown to effec-
tively substitute for Ca2+ in terms of protein function.18,19
For example, Tb3+ binding to b1-bungarotoxin stimulates the
protein’s phospholipase A2 activity.20 For others, such as Gd3+
binding to stretch activated Ca2+ channels, lanthanide ions have
a potent inhibitory effect.21–23 Given their wide-ranging applica-
tion in biology, it is important to understand the bioactivity of
lanthanides on Ca2+-binding proteins.
Cadherins are a large family of calcium-dependent membrane
proteins with over 100 members. Cadherins have vital roles in
embryo development and tissue homeostasis, and a number of
human diseases, such as cancer, are associated with alterations
in cadherin function.24–27 Cadherins facilitate cell–cell adhe-
sion through trans-binding of their extracellular regions, which
are known as ectodomains.28 The ectodomains of classical
cadherins are composed of five extracellular domains (EC1–5),
which are connected by flexible linker regions. X-ray crystal
structures indicate that three Ca2+ ions can bind at each of the
four linker regions and that the cadherin protein gradually
attains its functional conformation as Ca2+ ions bind to the
12 binding sites.29–31 Successive Ca2+-binding results in the
precise relative positioning of EC domains and imparts rigidity
and curvature onto the cadherin molecule which is an essential
feature for cadherin function.32–34 Furthermore, as Ca2+ ions
bind to a cadherin molecule, the binding affinity for successive
Ca2+ ions increases due to cooperativity in binding and con-
formational changes which are transmitted distally along the
cadherin.35,36 Whether lanthanides can bind cadherins and
effectively replace calcium in supporting cadherin function
has not been comprehensively investigated.
In this study, we investigated the binding of the lanthanide
Tb3+ to two classical cadherins with fundamental functions
in embryo development and tumour metastasis, E-cadherin
and N-cadherin. Cell-based assays, protein biophysics and
molecular dynamics have been used to demonstrate that Tb3+
competes with Ca2+ for binding to cadherin Ca2+-binding sites,




Chinese hamster ovary cells were stably transfected with
human N-cadherin (N-CHO cells) or human E-cadherin
(E-CHO cells) using Lipofectamine 2000 (Thermo), and cells
were selected for expression using G418 (Gibco). Parental
CHO, N-CHO and E-CHO cells were cultured in DMEM/F12
1 : 1 (Gibco) containing 10% FBS (Gibco). Hs578t and MCF-7
cells were obtained from ATCC and were cultured in DMEM
containing 10% FBS. Culture media for Hs578t additionally
contained 10 mg mL1 bovine insulin (Sigma).
Aggregation assays
Monolayer cell cultures were treated with 0.01% trypsin + 1 mM
CaCl2 in HBSS (Gibco) for 30 minutes at 37 1C. This trypsin
treatment dissociates monolayers into single cells whilst
leaving surface cadherins intact. Cells were resuspended in
HBSS + 1% BSA (Sigma) + 10% FBS to inhibit further trypsin
degradation and then resuspended in HBSS + 1% BSA to give a
concentration of 150 000 cells per 50 mL. 150 000 cells were
seeded into 24-well ultra-low attachment plates (Corning
Costar) in 0.5 mL HBSS + 1% BSA containing CaCl2, TbCl3
or combinations of both. Plates were rotated horizontally at
75 rpm at 37 1C on an orbital shaker Model 3500 (WR) for either
30 minutes (N-CHO) or 40 minutes (E-CHO, Hs578t, MCF-7).
The aggregation potential was calculated by 1 minus the
number of single cells at end of aggregation (Ne) divided by
the number of single cells at the beginning of aggregation (Ns).
Aggregation potential = 1  Ne/Ns. The number of single cells
was quantified using a 0.2 mm Improved Neubauer haemocyto-
meter counting chamber (Hawksley).
Trypsin protection assays
1.5  106 cells were seeded into 10 cm culture plates (Triple
Red) with media 24 h prior to experimentation. The cells were
washed twice with HBSS and then incubated with HBSS + 5 mM
EDTA for 8 min to remove Ca2+ ions. Cells were washed
with HBSS and then incubated with HBSS + required ions
(Ca2+, EGTA, Tb3+) for 10 min. Trypsin (Sigma) was added to
a final concentration of 0.04% and cells were incubated for
80 min at 25 1C. Cells were then pelleted, resuspended in
HBSS + 0.5 mg trypsin inhibitor (Sigma) and placed on ice.
Western blotting
Cells were lysed and protein collected using MEM-PER Plus
membrane extraction kit (Thermo) with trypsin inhibitor and
Halt protease inhibitor cocktail (Thermo). Protein concen-
tration in samples was quantified using Pierce BCA Protein
Assay Kit (Thermo). Samples were boiled in SDS-DTT sample
buﬀer for 5 min, separated on an 8% SDS-polyacrylamide gel
and then transferred to a nitrocellulose membrane (Biorad).
The membrane was blocked with TBS-T (tris buﬀered saline
plus 0.1% Tween) + 5% milk for 1 hour at room temperature
and then incubated with primary antibody diluted in TBS-T +
5% milk overnight at 4 1C. Membranes were washed four times
in TBS-T and incubated with secondary antibody for 1 hour at
25 1C. Following four further washes in TBS-T, membranes were
developed with Luminata Western HRP substrate (Millipore) and
exposed using a ChemiDoc MP system (Biorad). Image collection
and analysis was performed with ImageLab software (Biorad).
Primary antibodies used include mouse anti-N-cadherin
(BD Biosciences, 610920) (1 : 2500), mouse anti-E-cadherin
(BD Biosciences, 610181) (1 : 2500), and rabbit anti-b-actin (Cell
Signaling Technology, 4970) (1 : 1000). Secondary antibodies
used include anti-mouse HRP-conjugate (Promega, W4021)
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Tb3+-FRET
Wild-type human E-cadherin recombinant protein fragment
aa155-710 (Sigma) was dialysed within 2  5 L 10 mM Tris–
HCl, 100 mM KCl, 120 mMNaCl (all Sigma) pH 7.4 at 4 1C using
Slide-A-Lyzer Dialysis cassettes (Thermo). The protein sample
was aliquoted and stored at 20 1C. E-cadherin titration and
Tb3+ titration experiments were carried out on a SpectraMax-M5
(Molecular Devices). For the E-cadherin titration, a stock
solution of E-cadherin was added to 100 mM TbCl3 in buffer
(10 mM Tris–HCl, 100 mM KCl, 120 mM NaCl) or buffer alone
and emission at 543 nm measured during excitation at 282 nm.
For the Tb3+ titration, a stock solution of Tb3+ was added to
43.7 nM E-cadherin in buffer and emission at 543 nm measured
during excitation at 282 nm. The fluorescence competition assay
was carried out on a Cary Eclipse Fluorescence Spectrophotometer
(Agilent). Stock concentrations of Ca2+ were added to 3 mM
E-cadherin in 170 mM Tb3+ and buffer. Emission was measured
at 542 nm during excitation at 280 nm. For all experiments, spectra
were corrected for the background contribution of Tb3+ to 542–
543 nm emissions by measuring and subtracting the 542–543 nm
emissions of each Tb3+ concentration in the absence of protein.
All samples were gently mixed and allowed to equilibrate for
15 minutes prior to data collection.
Molecular dynamics
The LEaP software, part of AmberTools, was used to generate
systems from the crystal structure of mouse E-cadherin (PDB
code 3Q2V).31,37 Residues 504–507 were not resolved by crystallo-
graphy and were modelled in using Pymol.38 Disulphide
bridges found in physiological conditions were generated in all
systems.31 The Ca-Ecad system consisted of the protein and the
12 crystallographically resolved Ca2+ ions found at the linker
regions between EC domains. All 12 crystallographically
resolved Ca2+ ions were replaced with Tb3+ ions for the
Tb-Ecad system, and the 12 Ca2+ ions were removed for the
Apo-Ecad system. All other crystallographically resolved non-
protein molecules were removed in systems. Systems were
neutralised through the addition of bulk Na+ ions and solvated
explicitly in boxes of TIP3P water molecules with edges no
closer than 10 Å from atoms in the protein.39
Simulations were carried out using the SANDER package in
Amber16 with the Parm99 parameter sets for Ca2+ and Tb3+
ions.37 For all simulations, 2 fs time steps were used and a
potential cut-oﬀ of 8 Å was assumed for van der Waals interactions.
Constant volume periodic boundary conditions were assumed.
The systems were minimized with 500 steps of steepest descent
minimization followed by 500 steps of conjugate gradient mini-
mization using 2 kcal mol1 Å2 quadratic constraints. After
minimisation, the temperature of the systems was increased to
300 K over 2500 steps using Langevin dynamics. Free molecular
dynamics simulations were then carried out for 40 ns.
The coordinates of atoms in the systems were saved every
10 ps during simulation and trajectories were analysed in
VMD.40,41 RMSDs were calculated using non-hydrogen atoms
in VMD.
Results
Tb3+ inhibits E-cadherin- and N-cadherin-mediated cell
adhesion
To investigate whether Tb3+ aﬀects cadherin-mediated cell
adhesion, cell aggregation assays were used which assess the
ability of single cells to form cadherin-dependent aggregates.
Cadherin-expressing cells were dissociated into single cells
using 0.01% trypsin + 1 mM Ca2+ treatment, which cleaves
proteins on the cell surface but does not aﬀect cadherins.
This treatment produces a single-cell population which can
only form adhesions and aggregates via cadherin-mediated cell
adhesion.30,42,43 To demonstrate that this method only permits
cadherin-mediated cell aggregation, parental CHO cells were
treated with 0.01% trypsin + 1 mM Ca2+ and assayed for 40 min
in the presence of 1 mM Ca2+. Parental CHO cells have no
endogenous cadherin expression and thus no aggregation was
observed (Fig. S1, ESI†).
In contrast, CHO cells stably expressing E-cadherin (E-CHO)
and CHO cells stably expressing N-cadherin (N-CHO)
formed dense aggregates within 40 minutes and 30 minutes
respectively in the presence of 1 mM Ca2+ (Fig. 1A and E).
However, no aggregation was visible in the presence of only
1 mM Tb3+ (Fig. 1B and F). Quantification of aggregation
through the counting of unaggregated single cells confirmed
that cadherin-mediated aggregation of E-CHO and N-CHO cells
is significantly reduced in 1 mM Tb3+ compared with aggregation
in 1 mMCa2+ (Fig. 1I and J). Interestingly, cell aggregation in 1 mM
Ca2+ + 1 mM Tb3+ was not significantly diﬀerent from that in 1mM
Ca2+, but cell aggregation was significantly inhibited for both
E-CHO and N-CHO cells in the presence of 1 mM Ca2+ + 2 mM
Tb3+ (Fig. 1C, D, G, H, I and J). Similar results were obtained in cell
aggregation assays in the presence of another lanthanide, Gd3+,
suggesting that cadherin-mediated cell adhesion is inhibited by
Ca2+-mimicking lanthanides (Fig. S2, ESI†).
In order to determine if Tb3+ had the same eﬀect on cells
expressing cadherins endogenously, aggregation assays using
two human cancer cell lines were carried out. MCF-7 is an
E-cadherin expressing breast cancer cell line and, similarly to
E-CHO, MCF-7 E-cadherin mediated cell aggregation was signifi-
cantly reduced in the presence of 1 mM Tb3+ and 1 mM Ca2+ +
2 mM Tb3+ compared with aggregation in the presence of 1 mM
Ca2+ (Fig. S3A–D, I, ESI†).44 In the N-cadherin expressing breast
cancer cell line Hs578t, cell aggregation was also significantly
impaired in 1 mM Tb3+ and 1 mM Ca2+ + 2 mM Tb3+ (Fig. S3E–
H, J, ESI†). Taken together, the lack of aggregation in 1mM Tb3+ for
all cell lines indicates Tb3+ cannot substitute for Ca2+ in mediating
E- and N-cadherin adhesion. Additionally, Tb3+ is able to inhibit
Ca2+-dependent cadherin cell adhesion when at a higher concen-
tration than Ca2+, suggesting competitive binding between the two
metal ions for cadherins.
Tb3+ does not protect E-cadherin or N-cadherin from trypsin
degradation
To determine how Tb3+ inhibits cadherin-mediated adhesion
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binding sites, trypsin resistance assays were carried out. When
cadherins are fully bound to Ca2+, they are resistant to trypsin-
mediated proteolysis when using a low concentration of
trypsin.30,42,43 This is because Ca2+-bound cadherins adopt a
rigid structural conformational that has no accessible trypsin
recognition sites. In the absence of Ca2+ binding, cadherins
adopt a flexible conformation that is sensitive to degradation as
the trypsin recognition sites can become exposed. Thus, by
assessing the resistance of cadherins to trypsin, we can demon-
strate whether Tb3+-bound cadherins diﬀer in structure or
rigidity to Ca2+-bound cadherins and determine if Tb3+ can
compete with Ca2+ for binding. Monolayers of E-CHO and
N-CHO cells were first stripped of Ca2+ via EDTA treatment
and then treated with a low concentration of trypsin (0.04%) in
the presence of diﬀerent combinations of Ca2+ and Tb3+ for
80 min. Proteins were then extracted and western blots were
carried out to analyse E-cadherin and N-cadherin proteins.
To measure how Ca2+ and Tb3+ protects E-cadherin and
N-cadherin from trypsin degradation, the densitometry of the
protein bands corresponding to full-length cadherin proteins
(120 kD for E-cadherin and 135 kD for N-cadherin) at each
condition was quantified after normalisation to a b-actin
protein loading control. The densitometry of the full-length
band in each treatment was expressed as relative to measure-
ment of the full-length band in the no trypsin control.
As expected, when E-CHO cells were treated with trypsin +
1 mM Ca2+, there was significantly more detectable full-length
E-cadherin than when E-CHO cells were treated with trypsin +
1 mM EGTA (Ca2+ chelator), demonstrating that Ca2+ is able to
protect E-cadherin from trypsin degradation (Fig. 2). However,
when cells were treated with trypsin + 1 mM Tb3+, significant
loss of full-length E-cadherin protein occurred, indicating Tb3+
oﬀers no trypsin protection to E-cadherin. Interestingly, trypsin
treatment of E-CHO cells in 1 mM Ca2+ + 1 mM Tb3+ resulted in
no significant diﬀerence in E-cadherin degradation compared
with trypsin + 1 mM Ca2+. However, when the concentration
of Tb3+ was greater than that of Ca2+, significant trypsin
degradation of E-cadherin protein was observed. Trypsin resis-
tance assays revealed similar results for N-CHO cells. Following
treatment of N-CHO cells with trypsin, N-cadherin was signifi-
cantly degraded when in the presence of 1 mM Tb3+ or 1 mM
Ca2+ + 2 mM Tb3+ compared with N-cadherin in the presence of
1 mM Ca2+. Importantly, when E-CHO and N-CHO cells were
incubated with the same combinations of Ca2+ and Tb3+ in the
Fig. 1 Influence of Tb3+ on cadherin-mediated cell aggregation. (A–D) Cell aggregation assays of E-cadherin expressing CHO (E-CHO) and (E–H)
N-cadherin expressing CHO (N-CHO) cells in different combinations of Ca2+ and Tb3+. Prior to aggregation, cells were treated with 0.01% trypsin + 1 mM
Ca2+. Aggregation potential of (I) E-CHO and (J) N-CHO cells. The aggregation potential was calculated by 1 minus the number of single cells at end of
aggregation (Ne) divided by the number of single cells at the beginning of aggregation (Ns). Aggregation potential = 1  Ne/Ns. Scatterplots show
individual values and bars represent the mean from four biological replicates (one-way ANOVA with Tukey’s multiple comparisons test, significant
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absence of trypsin, no significant diﬀerences in the amount of
full-length cadherin were observed among the samples (Fig. S4,
ESI†). This demonstrates that the diﬀerent ion conditions have
no eﬀect on cadherin expression levels and only eﬀect how
sensitive cadherins are to trypsin degradation.
These results show that cadherins are degraded by trypsin
when in the presence of Tb3+. Given that Ca2+-bound cadherin
are resistant to trypsin, this indicates that Tb3+-bound cadherins
adopt a diﬀerent and/or more flexible structure that has exposed
trypsin recognition sites. Additionally, when Tb3+ is present at a
higher concentration than Ca2+, cadherins become sensitive to
trypsin degradation. This suggests that Tb3+ has the ability to
displace Ca2+ from cadherins and compete with Ca2+ for binding
at cadherin Ca2+-binding sites.
Binding of Tb3+ to E-cadherin
The previous experiments suggest that Tb3+ binds cadherins
and competes with Ca2+ for binding at Ca2+-binding sites,
however direct biophysical evidence of this is required. In order
to gather this evidence, we measured the fluorescence reso-
nance energy transfer (FRET) between Tb3+ ions and human
E-cadherin EC1–5 recombinant protein. Tb3+ ions are naturally
fluorescent and their excitation is within the range of trypto-
phan and tyrosine emissions (348 nm and 303 nm respectively).
Thus, when tryptophan and tyrosine residues in E-cadherin are
excited (280–282 nm), one can quantify the amount of bound
Tb3+ ions by the FRET to Tb3+ ions and the resulting Tb3+
emission (542–543 nm).
There are 12 Ca2+-binding sites that Tb3+ ions might bind to,
but FRET can only take place at sites within 10 Å of a
tryptophan or tyrosine residue. There is no structure available
for human E-cadherin EC1–5, thus the crystal structure for
mouse E-cadherin EC1–5 (PDB 3Q2V) was used to identify
binding sites potentially capable of FRET. The human and
mouse homologues share an 81% sequence identity (450/
553), and tryptophan (6/6) and tyrosine (13/13) residues are
found in identical positions (Fig. S5B, ESI†).31,45 In the mouse
E-cadherin crystal structure, there are tryptophan and/or
tyrosine residues within 10 Å to binding sites 3 (EC1-2),
5 (EC2-3), 6 (EC2-3), 8 (EC3-4), and 10 (EC4-5) (Fig S5A, ESI†).
If Tb3+ ions were to bind to these sites in E-cadherin, one would
expect FRET to take place.
We first determined if FRET could be measured between
tryptophan and tyrosine residues in E-cadherin and Tb3+ ions
in order to confirm if Tb3+ binds to E-cadherin. E-cadherin was
either titrated into buﬀer (10 mM Tris–HCl, 100 mM KCl,
120 mM NaCl) or into buffer + 100 mM Tb3+, and Tb3+ fluores-
cence at 543 nm was measured following excitation at 282 nm.
In the absence of 100 mM Tb3+, the addition of E-cadherin
protein resulted in no change in 543 nm emission (Fig. 3A).
However, addition of E-cadherin protein to 100 mM Tb3+ resulted
in a linear increase of Tb3+ fluorescence emission at 543 nm.
Fig. 2 Protection of E-cadherin and N-cadherin from trypsin degradation by Ca2+ and Tb3+. Western blot of (A) E-cadherin after E-CHO cells and of
(B) N-cadherin after N-CHO cells were treated with 0.04% trypsin in the presence of 1 mM EGTA, 1 mM Ca2+, 1 mM Tb3+, 1 mM Ca2+ + 1 mM Tb3+, and
1 mM Ca2+ + 2 mM Tb3+ for 80 minutes. Control cells were not treated with trypsin and b-actin was used as a loading control. (C) Quantification of E-cad
expression normalised to b-actin expression and (D) N-cadherin expression normalised to b-actin expression. Densitometry is expressed as fold change
relative to the no trypsin control. Scatterplots show individual values and bars represent the mean from four biological replicates (one-way ANOVA with
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This result indicates that FRET can occur between tryptophan
and tyrosine residues in E-cadherin and bound Tb3+ ions, and
thus suggests that Tb3+ can directly bind E-cadherin molecules.
In order to quantify the binding aﬃnity of Tb3+ to
E-cadherin, Tb3+ was titrated into a solution of E-cadherin
and 543 nm emission was measured during 282 nm excitation.
Data was fit to a Hill model using non-linear regression and
the KD measured by this method was 143 mM (Fig. 3B). A Hill
coeﬃcient of 0.69 was obtained for the data, indicating
that binding of Tb3+ to the E-cadherin protein had negative
cooperativity.
A fluorescence competition assay was then carried out to
determine if Tb3+ and Ca2+ compete for the same sites on
E-cadherin. Ca2+ was titrated into a solution of E-cadherin in
170 mM Tb3+ and the change in Tb3+ fluorescence (542 nm) was
measured during excitation of tryptophan and tyrosine residues
(280 nm). Increasing the Ca2+ concentration reduced the level
of Tb3+ fluorescence, suggesting displacement of Tb3+ ions
at Ca2+-binding sites on E-cadherin by Ca2+ ions. Addition of
Ca2+ was unable to completely remove Tb3+ fluorescence
(B60% total reduction with a half-maximal eﬀect atB60 mM).
Diﬀerences in the molecular dynamics of Ca2+- and Tb3+-bound
E-cadherin
Our results indicate that Tb3+ can bind cadherins, but that
Tb3+-bound cadherins are non-functional. In order to investigate
the molecular basis of this, computational molecular dynamics
simulations were performed to predict the diﬀerences in struc-
ture and dynamics of a cadherin protein bound to Ca2+ or Tb3+.
Simulations were carried out using the crystal structure of the full
ectodomain of E-cadherin (PDB 3Q2V) resolved to 3.4 Å.31 Three
scenarios based on this E-cadherin were simulated: one with the
12 crystallographically resolved Ca2+ ions (Ca-Ecad), one with
the 12 Ca2+ ions replaced with Tb3+ ions (Tb-Ecad) and one with
the 12 Ca2+ ions removed (Apo-Ecad).
The replacement of Ca2+ with Tb3+ resulted in a re-structuring
of the cadherin linker regions, particularly in the charged resi-
dues in proximity to the metal ions (Fig. 4A and B). This is
unsurprising given the greater electropositivity of Tb3+ ions and
that Tb3+ ions typically exhibit higher coordination numbers
within proteins.16,29,31 However, due to the resolution of the
molecular dynamics simulations, it is not possible to comment
on the exact coordination geometry and coordinating ligands of
the metal ions. As expected, removal of Ca2+ in Apo-Ecad caused
significant structural changes in the linker region as negative
residues presumably undergo electrostatic repulsion (Fig. 4C).
Root mean-square deviations (RMSD) were used to deter-
mine how much the theoretical E-cadherin tertiary structure
changed over a simulation and the RMSD was calculated for
Ca-Ecad, Tb-Ecad and Apo-Ecad (Fig. 5). As observed in pre-
vious studies with other cadherin ectodomains, the E-cadherin
ectodomain experienced a higher RMSD, and thus higher
structural fluctuation, when in the absence of Ca2+ (Apo-Ecad,
RMSD average = 9.82 Å) compared when in the presence of
Ca2+ (Ca-Ecad, RMSD average = 4.19 Å).33,34,46 These results are
also consistent with structural studies which demonstrate the
rigidification of cadherin ectodomains upon Ca2+ binding.29,30
Interestingly, the E-cadherin ectodomain in the presence of
Tb3+ (Tb-Ecad, RMSD average = 9.74 Å) had a high overall RMSD
Fig. 3 Tb3+ binding to E-cadherin measured by Tb3+-FRET. (A) Fluores-
cence at 543 nm in the absence and presence of 100 mM Tb3+ when
excited at 282 nm with increasing amounts of E-cadherin protein. Data
points are normalised to fluorescence at 0 mME-cadherin. (B) Fluorescence at
543 nm during excitation at 282 nm when increasing concentrations of
Tb3+ were added into 47.5 nM E-cadherin protein. Data points are fit to a
non-linear regression hill model using Graphpad Prism. (C) Fluorescence at
542 nm during excitation at 280 nm when increasing concentrations of Ca2+
were added into 3 mM E-cadherin protein with 170 mM Tb3+. Data points are
normalised to fluorescence at 0 mM Ca2+. Smoothed curves are fitted for
visualisation. All graphs plotted from three biological repeats; error bars
represent the SEM. All measurements were performed in 10 mM Tris–HCl,
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that was similar to Apo-Ecad ectodomains, indicating a high
level of structural flexibility. It is important to note that,
like Ca2+ ions, all Tb3+ ions remained bound within the
Ca2+-binding sites over the course of the simulation.
In order to compare how the structure and dynamics of the
E-cadherin ectodomain diﬀer in the presence of Ca2+ and Tb3+,
the end-to-end distance and curvature of the ectodomains were
measured (Fig. 6). The distance between a-Carbon atoms of two
distal residues, Glu31 and Arg451, was measured for both
scenarios over the 40 ns simulation. It was found that the
E-cadherin ectodomain had a longer average end-to-end dis-
tance when in presence of Tb3+ compared with Ca2+ (209.6 Å vs.
192.6 Å). The curvatures of the ectodomains were compared by
measuring the angle made between a-Carbon atoms of distal
residues Glu31 and Arg451, and the residue that was closest
to the geometric centre of EC3, Leu282. The curvature angle of
the E-cadherin ectodomain with Tb3+ was also found to be
larger than that for the ectodomain with Ca2+ (146.11 vs. 123.41).
Together these results suggest that the binding of Tb3+ leads to
significant structural changes in the E-cadherin ectodomain and
Fig. 4 E-cadherin linker regions in the presence of Ca2+ and Tb3+ ions.
Snapshots of the linker region between repeats EC1–EC2 of E-cadherin in
the presence of (A, Ca-Ecad) Ca2+, (B, Tb-Ecad) Tb3+, or (C, Apo-Ecad)
absence of Ca2+ and Tb3+ ions after 40 ns of simulated free molecular
dynamics. Ca2+ ions are represented as green spheres and Tb3+ ions are
represented as purple spheres. Residues in proximity to metal ions are
shown in liquorice representation.
Fig. 5 Influence of Ca2+ and Tb3+ ions on the molecular dynamics of the
E-cadherin ectodomain. RMSD of the E-cadherin ectodomain in the
(A, Ca-Ecad) presence of Ca2+, (C, Tb-Ecad) presence of Tb3+ or
(E, Apo-Ecad) absence of Ca2+ and Tb3+ during 40 ns of simulated free
molecular dynamics. (B, D and F) Snapshots of the ectodomains at the end
of the simulation. Ca2+ ions are represented as green spheres and Tb3+
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results in elongated structures with more shallow curvature com-
pared with Ca2+-bound E-cadherin ectodomains. Furthermore,
the Tb-Ecad ectodomain had greater fluctuation in both the
end-to-end distance (Tb-Ecad, SD = 9.32 Å vs. Ca-Ecad, SD =
3.30 Å) and curvature angle (Tb-Ecad, SD = 10.661 vs. Ca-Ecad,
SD = 3.181), which indicates greater structural flexibility in the
Tb3+-bound ectodomain. The outcomes from the simulations
agree well with our experimental data, which demonstrated that
Tb3+-bound cadherins cannot mimic the functional conformation
of Ca2+-bound cadherins.
Our molecular dynamics simulations were used here to
explore the impact of metal ion chemistry on cadherin struc-
ture and dynamics and provide atomistic explanations for our
experimental findings. Further experimental work, such as
crystallography or NMR, would be necessary to validate these
computational predictions.
Discussion
The present study shows that Tb3+ inhibits cadherin-mediated
cell adhesion and our evidence suggests that this is a result of
competitive binding at cadherin Ca2+-binding sites. Cadherins
require Ca2+-binding at all 12 sites in order to achieve a
functional conformation and loss of Ca2+-binding at a single
site is suﬃcient to disrupt cadherin-mediated cell adhesion.36,47
Here, we demonstrate that Tb3+ functions as a competitive
antagonist in Ca2+-dependent cadherin-mediated cell aggrega-
tion assays and our trypsin resistance assays suggest that Tb3+
competes with Ca2+ for binding to cadherins. Furthermore,
Tb3+ is a well-documented mimic of Ca2+ in biological
processes and our molecular dynamics simulations show that
Tb3+ remained bound within Ca2+-binding sites throughout the
simulations. This is in contrast to Na+ and K+, which have no
experimental evidence of binding to cadherins and these ions
become unbound from cadherin Ca2+-binding sites during
simulations.33 The Tb3+ FRET experiments additionally provide
biophysical evidence for Tb3+ binding to cadherins and suggest
that Tb3+ ions compete for the same sites as Ca2+ ions.
Results from the fluorescence competition assay demonstrate
that not all the observed Tb3+ fluorescence can be attributed to
Tb3+ binding at Ca2+-binding sites. This might be an artefact of
Tb3+ autofluorescence or potentially the result of Tb3+ binding to
E-cadherin at sites other than Ca2+-binding sites. Whether Tb3+
binding at non-Ca2+-binding sites is possible and what eﬀect this
might have on cadherin structure remains to be determined.
It is not possible to determine at how many or at which
Ca2+-binding sites Tb3+ ions can bind to. Only 5 out of the 12
Ca2+-binding sites in human E-cadherin are potentially repor-
table by FRET, and of these 5 sites one cannot accurately
calculate how binding at each site would contribute to the
Tb3+ fluorescence signal. For the same reasons, it is unknown
Fig. 6 Tertiary structural diﬀerences between E-cadherin bound to Ca2+ and Tb3+. (A) End-to-end distance of the E-cadherin ectodomain in the
presence of Ca2+ (Ca-Ecad) or Tb3+ (Tb-Ecad) during 40 ns of simulated free molecular dynamics. (B and C) Snapshots of the ectodomains at the end of
the simulation. Ca2+ ions are represented as green spheres and Tb3+ ions are represented as purple spheres. Black dotted line indicates the end-to-end
distance drawn between identical atoms in Ca-Ecad and Tb-Ecad. (D) Angle of curvature of the E-cadherin ectodomain in the presence of Ca2+
(Ca-Ecad) or Tb3+ (Tb-Ecad) during 40 ns of simulated free molecular dynamics. (E and F) Snapshots of the ectodomains at the end of the simulation.
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how many Tb3+ ions could bind each E-cadherin molecule
at non-Ca2+-binding sites. There might only be a very small
amount of Tb3+ binding to non-Ca2+-binding sites but this
binding might contribute to a large amount of the observed
Tb3+ fluorescence, which is dependent on the distances
between Tb3+ ions and tryptophan and tyrosine residues.
Structural determination studies would be required to conclude
exactly where and how Tb3+ binds to cadherins.
The ratio of [Tb3+] : [Ca2+] required to inhibit cell adhesion
and cadherin trypsin protection suggests that Ca2+ has a higher
binding aﬃnity than Tb3+ to cadherins. The competition
fluorescence assay additionally suggests this as B60 mM Ca2+
had a half-maximal eﬀect in reducing Tb3+ fluorescence in
E-cadherin when in the presence of 170 mM Tb3+. A diﬀerence
in binding aﬃnity does not, however, fully explain why a steep
dose–response relationship was observed for the cellular
assays: no effect was observed at a [Tb3+] : [Ca2+] ratio of 1 : 1
but effective inhibition was seen at a ratio of 2 : 1. One explana-
tion for these results is the potential binding of Tb3+ to both
Ca2+- and non-Ca2+-binding sites on cadherins. At a ratio of
1 : 1, Tb3+ might bind elsewhere on cadherins as Ca2+ occupies
the Ca2+-binding sites, but at a ratio of 2 : 1, Tb3+ may be at
a sufficiently high concentration to outcompete Ca2+ for the
Ca2+-binding sites and thus inhibit the Ca2+-dependent
cadherin processes.
It would be unusual if Tb3+ had a weaker binding aﬃnity
than Ca2+ to cadherins. Tb3+ typically binds more strongly to
Ca2+-binding proteins, such as calmodulin, due to the greater
electropositivity of Tb3+.16,17 One possible explanation for the
apparent higher binding aﬃnity of Ca2+ to cadherins is that
Ca2+ binds to the 12 sites on cadherins with a high level of
coorperativity.35,36,48 Binding of Ca2+ to one Ca2+-binding site
induces specific structural changes that enhances the binding
aﬃnity of Ca2+ to the other sites on a cadherin molecule. Given
that the extensive cooperativity of Ca2+ binding requires a
precise network of molecular interactions across 12 binding
sites, it is plausible that slight diﬀerences in metal chemistry
result in Tb3+ being unable to mimic the cooperative binding of
Ca2+ to cadherins. Results from the Tb3+ FRET assay suggest
that Tb3+ binds to E-cadherin with negative cooperativity
(KD = 143 mM, hill coeﬃcient = 0.69), however values from this
experiment should be treated with caution, as they are not
specific for Tb3+ binding to only Ca2+-binding sites. Overall, it is
possible that Ca2+-cooperative binding may be essential for
cadherin’s preferential binding of Ca2+ over other ions. This
may be one mechanism by which cadherins maintain robust
function in stochastic biological environments.
Upon Tb3+ binding to cadherins, data from trypsin protec-
tion assays indicate that cadherins diﬀer in structure and/or
conformational flexibility to Ca2+-bound cadherins. Molecular
dynamics simulations support these findings and suggest that
Tb3+-bound cadherins have a more elongated, less curved
structure that exhibits enhanced structural fluctuations. These
changes in tertiary structure are likely responsible for the
inability of Tb3+-bound cadherins to support cell adhesion.
Interestingly, a recent study found that binding of Tb3+ to
another Ca2+-dependent protein, calmodulin, resulted in enhanced
structural flexibility within Ca2+-binding sites and this was caused
by the more electropositive Tb3+ adopting an alternative and more
disordered coordination geometry.49 In the case of cadherins,
changes in coordination geometry and flexibility within binding
sites may also be the chemical driving forces behind global
diﬀerences in Tb3+-bound and Ca2+-bound molecules. However,
unlike in calmodulin, cadherins are non-functional upon binding
to Tb3+, which provides further insight into the high level of
sensitivity of cadherins to Ca2+ chemistry.50,51 Overall, it is fascinat-
ing that seemingly slight diﬀerences in the chemistry between Tb3+
and Ca2+ can significantly influence the structure, dynamics and
function of cadherin proteins. Follow-on structural determination
studies would be invaluable in providing conclusive evidence for
how substitution of Ca2+ with Tb3+ aﬀects the tertiary structure of
cadherins and interactions within the binding sites.
We also show that Gd3+ inhibits cadherin adhesion in a
similar Ca2+-competing manner and there is some evidence of
La3+ competing with Ca2+ for binding to cadherins.52 Many
lanthanide ions are known to chemically mimic Ca2+ and
the Ca2+-binding pockets of classical cadherins are highly
conserved, thus one would predict that the interaction eluci-
dated here is universal between lanthanides and classical
cadherins.16,53
Conclusion
Cadherin adhesions have widespread roles in physiology and
there is a growing appreciation for how the interaction of
cadherins with non-Ca2+ ions can regulate cadherin function.
For example, Zn2+ ions have been shown to bind and inhibit
N-cadherin binding and this interaction is believed to play a
regulatory role in synaptic plasticity.54,55 Here, the lanthanide
Tb3+, which has applications in protein spectroscopy and
cancer therapy, was found to compete with Ca2+ for binding
to cadherins. We show that Tb3+-bound cadherins are unable to
support cell adhesion and demonstrate this is a result of
diﬀerences in the structure and dynamics of cadherins following
Ca2+- and Tb3+-binding. Unlike in other Ca2+-dependent proteins,
Tb3+ cannot functionally-replace Ca2+ in cadherins and our work
provides new insight into the sensitivity of cadherin structure,
dynamics and function to the chemistry of Ca2+. Furthermore,
our characterisation of the interaction between lanthanides and
cadherins should be of value as lanthanides continue to be used
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